Edwards Lifesciences's JenaValve deal faces in-depth Austrian review
Edwards Lifesciences's takeover of JenaValve Technology, a US medical devices company making an innovative treatment for heart disease, has triggered an in-depth competition investigation in Austria. The probe adds to the...To view the full article, register now.
Already a subscriber? Click here to view full article